Related references
Note: Only part of the references are listed.Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis
Marcos Antonio Pereira de Lima et al.
GYNECOLOGIC ONCOLOGY (2018)
Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers
Jennifer E. Cameron et al.
SEXUALLY TRANSMITTED DISEASES (2018)
High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7
Sirinart Aromseree et al.
PLOS ONE (2017)
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Suzanne M. Garland et al.
CLINICAL INFECTIOUS DISEASES (2016)
Human Papillomavirus-Ass
Laura J. Viens et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Possible contributing role of Epstein-Barr virus (EBV) as a cofactor in human papillomavirus (HPV)-associated cervical carcinogenesis
Sirinart Aromseree et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Epstein-Barr Virus Antibodies and the Risk of Associated Malignancies: Review of the Literature
Anna E. Coghill et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal
Joana Marinho-Dias et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Human Papillomavirus and Epstein-Barr virus co-infection in Cervical Carcinoma in Algerian women
Abdelhalim Khenchouche et al.
VIROLOGY JOURNAL (2013)
Shedding of Epstein-Barr Virus and Cytomegalovirus from the Genital Tract of Women in a Periurban Community in Andhra Pradesh, India
Michelle I. Silver et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive?
Wafa Habbal et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Is the Epstein-Barr virus EBNA-1 protein an oncogen?
Thomas F. Schulz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?
C Söderberg-Nauclér
JOURNAL OF INTERNAL MEDICINE (2006)
Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation
F Cinatl et al.
MEDICINAL RESEARCH REVIEWS (2005)
Biology of Epstein-Barr virus during infectious mononucleosis
DL Sitki-Green et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression
J Cinatl et al.
FEMS MICROBIOLOGY REVIEWS (2004)
Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments - A novel approach to screen for the virus in paraffin-embedded tissue and plasma
JL Ryan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Clearance of HPV infection in middle aged men and women after 9 years' follow up
S de Sanjose et al.
SEXUALLY TRANSMITTED INFECTIONS (2003)
Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling
CW Dawson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Environmental co-factors in HPV carcinogenesis
X Castellsagué et al.
VIRUS RESEARCH (2002)
Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells
Y Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Share Paper
